Literature DB >> 29399948

A parent-of-origin analysis of paternal genetic variants and increased risk of conotruncal heart defects.

Wendy N Nembhard1,2, Xinyu Tang3, Jingyun Li3, Stewart L MacLeod1, Joseph Levy1, Gerald B Schaefer4, Charlotte A Hobbs1.   

Abstract

The association between conotruncal heart defects (CTHDs) and maternal genetic and environmental exposures is well studied. However, little is known about paternal genetic or environmental exposures and risk of CTHDs. We assessed the effect of paternal genetic variants in the folate, homocysteine, and transsulfuration pathways on risk of CTHDs in offspring. We utilized National Birth Defects Prevention Study data to conduct a family-based case only study using 616 live-born infants with CTHDs, born October 1997-August 2008. Maternal, paternal and infant DNA was genotyped using an Illumina® Golden Gate custom single nucleotide polymorphism (SNP) panel. Relative risks (RR) and 95% confidence intervals (CI) from log-linear models determined parent of origin effects for 921 SNPs in 60 candidate genes involved in the folate, homocysteine, and transsulfuration pathways on risk of CTHDs. The risk of CTHD among children who inherited a paternally derived copy of the A allele on GLRX (rs17085159) or the T allele of GLRX (rs12109442) was 0.23 (95%CI: 0.12, 0.42; p = 1.09 × 10-6 ) and 0.27 (95%CI: 0.14, 0.50; p = 2.06 × 10-5 ) times the risk among children who inherited a maternal copy of the same allele. The paternally inherited copy of the GSR (rs7818511) A allele had a 0.31 (95%CI: 0.18, 0.53; p = 9.94 × 10-6 ] risk of CTHD compared to children with the maternal copy of the same allele. The risk of CTHD is less influenced by variants in paternal genes involved in the folate, homocysteine, or transsulfuration pathways than variants in maternal genes in those pathways.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  congenital heart defect; conotruncal heart defects; genetic variants; parent-of-origin; paternal genetic variants

Mesh:

Year:  2018        PMID: 29399948      PMCID: PMC5881110          DOI: 10.1002/ajmg.a.38611

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  73 in total

1.  Methods for detection of parent-of-origin effects in genetic studies of case-parents triads.

Authors:  C R Weinberg
Journal:  Am J Hum Genet       Date:  1999-07       Impact factor: 11.025

2.  Risk factors of different congenital heart defects in Guangdong, China.

Authors:  Yanqiu Ou; Jinzhuang Mai; Jian Zhuang; Xiaoqing Liu; Yong Wu; Xiangmin Gao; Zhiqiang Nie; Yanji Qu; Jimei Chen; Christine Kielb; Ursula Lauper; Shao Lin
Journal:  Pediatr Res       Date:  2015-12-17       Impact factor: 3.756

3.  Effect of fathers' age and birth order on occurrence of congenital heart disease.

Authors:  S Y Zhan; Z H Lian; D Z Zheng; L Gao
Journal:  J Epidemiol Community Health       Date:  1991-12       Impact factor: 3.710

Review 4.  A census of mammalian imprinting.

Authors:  Ian M Morison; Joshua P Ramsay; Hamish G Spencer
Journal:  Trends Genet       Date:  2005-08       Impact factor: 11.639

5.  Sidestream tobacco smoke is a male germ cell mutagen.

Authors:  Francesco Marchetti; Andrea Rowan-Carroll; Andrew Williams; Aris Polyzos; M Lynn Berndt-Weis; Carole L Yauk
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-18       Impact factor: 11.205

6.  Advancing age has differential effects on DNA damage, chromatin integrity, gene mutations, and aneuploidies in sperm.

Authors:  A J Wyrobek; B Eskenazi; S Young; N Arnheim; I Tiemann-Boege; E W Jabs; R L Glaser; F S Pearson; D Evenson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-09       Impact factor: 11.205

7.  Maternal age and malformations in singleton births.

Authors:  L M Hollier; K J Leveno; M A Kelly; D D MCIntire; F G Cunningham
Journal:  Obstet Gynecol       Date:  2000-11       Impact factor: 7.661

8.  Integration of DNA sample collection into a multi-site birth defects case-control study.

Authors:  Sonja A Rasmussen; Edward J Lammer; Gary M Shaw; Richard H Finnell; Robert E McGehee; Margaret Gallagher; Paul A Romitti; Jeffrey C Murray
Journal:  Teratology       Date:  2002-10

9.  PREMIM and EMIM: tools for estimation of maternal, imprinting and interaction effects using multinomial modelling.

Authors:  Richard Howey; Heather J Cordell
Journal:  BMC Bioinformatics       Date:  2012-06-27       Impact factor: 3.169

10.  Maternal obesity and tobacco use modify the impact of genetic variants on the occurrence of conotruncal heart defects.

Authors:  Xinyu Tang; Todd G Nick; Mario A Cleves; Stephen W Erickson; Ming Li; Jingyun Li; Stewart L MacLeod; Charlotte A Hobbs
Journal:  PLoS One       Date:  2014-10-02       Impact factor: 3.240

View more
  4 in total

1.  Paternal eNOS deficiency in mice affects glucose homeostasis and liver glycogen in male offspring without inheritance of eNOS deficiency itself.

Authors:  Berthold Hocher; Yong-Ping Lu; Christoph Reichetzeder; Xiaoli Zhang; Oleg Tsuprykov; Jan Rahnenführer; Li Xie; Jian Li; Liang Hu; Bernhard K Krämer; Ahmed A Hasan
Journal:  Diabetologia       Date:  2022-04-30       Impact factor: 10.460

2.  Gene-by-gene interactions associated with the risk of conotruncal heart defects.

Authors:  Chen Lyu; Daniel M Webber; Stewart L MacLeod; Charlotte A Hobbs; Ming Li
Journal:  Mol Genet Genomic Med       Date:  2019-12-18       Impact factor: 2.183

3.  Paternal genetic variants and risk of obstructive heart defects: A parent-of-origin approach.

Authors:  Jenil Patel; Emine Bircan; Xinyu Tang; Mohammed Orloff; Charlotte A Hobbs; Marilyn L Browne; Lorenzo D Botto; Richard H Finnell; Mary M Jenkins; Andrew Olshan; Paul A Romitti; Gary M Shaw; Martha M Werler; Jingyun Li; Wendy N Nembhard
Journal:  PLoS Genet       Date:  2021-03-08       Impact factor: 5.917

Review 4.  Evidence for germline non-genetic inheritance of human phenotypes and diseases.

Authors:  Liana Senaldi; Matthew Smith-Raska
Journal:  Clin Epigenetics       Date:  2020-09-11       Impact factor: 7.259

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.